cbdMD (AMEX: YCBD)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.100 | ||||||
REV | 10.000M | 9.628M | -372.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of cbdMD (AMEX: YCBD) through any online brokerage.
There are no as such competitors for cbdMD.
The latest price target for cbdMD (AMEX: YCBD) was reported by Cantor Fitzgerald on Friday, June 18, 2021. The analyst firm set a price target for 3.25 expecting YCBD to rise to within 12 months (a possible 641.16% upside). 0 analyst firms have reported ratings in the last year.
The stock price for cbdMD (AMEX: YCBD) is $0.4385 last updated July 1, 2022, 7:47 PM UTC.
There are no upcoming dividends for cbdMD.
cbdMD’s Q3 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for cbdMD.
cbdMD is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the AMEX.